ELTX today
$1.54-$0.02 (-1.28%)close Nov 13, 2026Trend
DailyDowntrend (confirmed)
4 hourDescending Triangle
1 hourSymmetric Triangle
15 minStrong Bearish
5 minLeaning Bearish
Daily trend turns up above $1.98
Key levels
Resistance$1.98
Resistance$1.77
Support$1.44
Support$1.25
Latest news & SEC filings
AnalystHC Wainwright keeps Buy rating on Elicio Therapeutics, cuts target to $21
EarningsElicio Therapeutics Posts Q3 2026 Results, Gives Clinical Program Update
EarningsElicio Therapeutics posts smaller Q3 loss than expected
All ELTX news →About Elicio
Elicio Therapeutics is a clinical-stage biotechnology company developing immunotherapies for cancer. Its lead candidate, ELI-002 7P, targets KRAS-mutated solid tumors such as pancreatic, colorectal, and lung cancers. The company's Amphiphile technology aims to deliver treatments to lymph nodes to stimulate T cell responses. It also has preclinical programs for BRAF- and TP53-driven cancers.
Based on the company's 10-K filed Mar 12, 2026.
Nasdaq · Healthcare
Elicio Therapeutics, Inc. (ELTX)
What Is the Price Target for ELTX?
SEPT Low Target
$8.00
SEPT Mid Target
$10.00
SEPT High Target
$12.00
Analyst Consensus
$10.00
Is ELTX a Buy or Sell Right Now?
Thesis
- •Revenue growing -91.9% YoY with UNKNOWN trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ELTX.
Start Free Trial →Is ELTX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$7.77
0
Moat Score
NONE
4/9
Piotroski Score
-16.4
Altman Z-Score
What Is Smart Money Doing with ELTX?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ELTX Growth Story
Revenue YoY
-91.9%
3yr Revenue CAGR
N/A%
EPS Growth YoY
39.29%
FCF Growth YoY
0.5%
Revenue Trend
UNKNOWN
Dark Pool Trades for ELTX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ELTX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 16:49:59 | $1.55 | 1,000 | $$2K | BUY |
| 16:46:18 | $1.55 | 1,000 | $$2K | SELL |
| 16:42:19 | $1.55 | 2,000 | $$3K | SELL |
| 16:31:14 | $1.56 | 1,850 | $$3K | MIDPOINT |
| 15:11:22 | $1.55 | 1,200 | $$2K | MIDPOINT |
5 dark pool trades shown · $$11K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for ELTX
PREVIEWSEPT Investing provides real-time options flow tracking for ELTX, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $2.5 | May 21 | 189 | $$175 | 5 | SWEEP |
| CALL | $2.5 | May 21 | 189 | $$70 | 2 | SWEEP |
| CALL | $2.5 | May 21 | 189 | $$175 | 5 | SWEEP |
| CALL | $2.5 | May 21 | 189 | $$70 | 2 | SWEEP |
| CALL | $2.5 | May 21 | 189 | $$175 | 5 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
What Traders Are Saying About ELTX
1 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for ELTX. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
$eltx is scheduled to report on thu nov 12.
Join 3,500+ traders discussing ELTX in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Elicio Therapeutics, Inc. (ELTX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ELTX — frequently asked questions
What is ELTX stock price today?
Elicio Therapeutics, Inc. (ELTX) is at $1.54, down 1.28% (-$0.02) at the Nov 13, 2026 close.
Why is ELTX stock moving today?
Latest ELTX news — Nov 10, 2026: HC Wainwright keeps Buy rating on Elicio Therapeutics, cuts target to $21 · Nov 6, 2026: Elicio Therapeutics Posts Q3 2026 Results, Gives Clinical Program Update
What is the ELTX price target?
The average analyst price target for ELTX is $10.00, ranging from $8 to $12, based on 2 analysts. Latest: B. Riley Securities maintains on Sep 24, 2026.
What do analysts rate ELTX?
Analyst ratings for ELTX: 0 Buy, 7 Hold, 1 Sell — consensus Hold.
Did ELTX beat earnings?
ELTX last reported on Aug 13, 2026: EPS -$0.43 vs -$0.54 expected — a beat of 20.0%.
Does ELTX pay a dividend?
ELTX does not currently pay a dividend.
What are ELTX support and resistance levels?
Support: $1.44, $1.25. Resistance: $1.77, $1.98, $2.72.
What are insiders doing with ELTX?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on ELTX?
Nov 10, 2026: HC Wainwright keeps Buy rating on Elicio Therapeutics, cuts target to $21 · Nov 6, 2026: Elicio Therapeutics Posts Q3 2026 Results, Gives Clinical Program Update · Nov 5, 2026: Elicio Therapeutics posts smaller Q3 loss than expected